Surface assay results generated much speculation in shares of a junior explorer Tuesday. Here’s some small stocks making big moves on Tuesday, April 16, 2019 (as of 4 pm EST):
Max Resource Corp. (TSXV:MXR) shares gained as much as 25% on Tuesday after the junior explorer announced surface assay results from ongoing exploration on its Choco Gold and Platinum Project in Colombia, with one sample grading 340.84 g/t gold and 111.03 g/t platinum.
As well, shares of Sokoman Minerals Corp. (TSXV:SIC) plunged 42% to $0.11 as the gold explorer released assay results from Phase 3 diamond drilling at its Moosehead Gold Project in Newfoundland, which included 4.8 metres of 33.59 g/t gold starting at a downhole depth of 239.85 metres.
MediPharm Labs Corp. (TSXV:LABS), meanwhile, reported that it has received Depository Trust Company eligibility for its common shares in the United States. MediPharm Labs stock moved up 4% to $5.89 following the announcement.
Finally, Aleafia Health Inc. (TSX:ALEF) shares rose as much as 7% after the medical cannabis company announced that it will add 50,000 kg of extraction capacity with the Phase II expansion of the Company’s processing facility in Paris, ON.
Aleafia Health Inc. (TSX:ALEF) andMax Resource Corp. (TSXV:MXR) are featured sponsored companies and have paid SmallCapPower.com a fee for coverage. To learn more, see our full disclosure HERE >>
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.